Pulsenmore Ltd. (TLV:PULS)
Israel · Delayed Price · Currency is ILS · Price in ILA 515.00
+48.70 (10.44%)
Sep 11, 2025, 5:24 PM IDT
Pulsenmore Market Cap
Pulsenmore has a market cap or net worth of 267.26 million as of September 12, 2025. Its market cap has increased by 27.27% in one year.
Market Cap
267.26M
Enterprise Value
165.35M
Revenue
9.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
515.00
Market Cap Chart
Since June 15, 2021, Pulsenmore's market cap has decreased from 795.01M to 267.26M, a decrease of -66.38%. That is a compound annual growth rate of -22.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2025 | 267.26M | 6.22% |
| Dec 31, 2024 | 251.62M | -29.08% |
| Dec 31, 2023 | 354.81M | -4.28% |
| Dec 29, 2022 | 370.68M | -42.16% |
| Dec 30, 2021 | 640.93M | -19.38% |
| Jun 15, 2021 | 795.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 76.30B |
| Danel (Adir Yeoshua) | 2.89B |
| Kamada | 1.36B |
| BrainsWay | 991.19M |
| SofWave Medical | 980.61M |
| Bait Bakfar | 979.07M |
| Novolog (Pharm-Up 1966) | 757.12M |
| Ilex Medical | 708.32M |